BCR and neoplasm: PSADR1M (PSA1M/iPSA) in this study, calculated according to the maximum Youden index, can more intuitively reflect the extent of the PSA decrease and is a novel predictor that is both timely and effective for predicting BCR and evaluating tumor status.